Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer

Published:2021-02-04 Issue:2 Volume:43 Page:176-182
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Waki Kayoko¹,Yokomizo Kanako¹,Yoshiyama Koichi²,Takamori Shinzo²,Komatsu Nobukazu³,Yamada Akira¹

Affiliation:

1. Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan

2. Department of Surgery, Kurume University School of Medicine, Kurume, Japan

3. Department of Immunology, Kurume University School of Medicine, Kurume, Japan

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2021.1872619

Reference31 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

3. The biology and management of non-small cell lung cancer

4. ASCO 2018 NSCLC highlights—combination therapy is key

5. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Cell-Free DNA Is a Potential Biomarker for Diagnosis of Calcific Aortic Valve Disease;Cardiology;2023-10-27

2. Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review;Vaccines;2022-09-21

3. ALU repeat as potential molecular marker in the detection and prognosis of different cancer types: A systematic review;Molecular and Clinical Oncology;2022-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3